Your browser doesn't support javascript.
loading
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
Vossler, David G; Knake, Susanne; O'Brien, Terence J; Watanabe, Masako; Brock, Melissa; Steiniger-Brach, Björn; Williams, Paulette; Roebling, Robert.
Afiliação
  • Vossler DG; Department of Neurology, University of Washington, Seattle, Washington, USA david_vossler@valleymed.org.
  • Knake S; Neuroscience Institute, Valley Medical Center, Renton, Washington, USA.
  • O'Brien TJ; Department of Neurology, Epilepsy Centre Hessen, Philipps-University Marburg, Marburg, Germany.
  • Watanabe M; Department of Neurosciences, Monash University, Melbourne, Victoria, Australia.
  • Brock M; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
  • Steiniger-Brach B; Shinjuku Neuro Clinic, Tokyo, Japan.
  • Williams P; Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Roebling R; UCB Pharma, Raleigh, North Carolina, USA.
J Neurol Neurosurg Psychiatry ; 91(10): 1067-1075, 2020 10.
Article em En | MEDLINE | ID: mdl-32817358

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia Generalizada / Lacosamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia Generalizada / Lacosamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article